Skip to main content
Clinical Trials/NCT00743054
NCT00743054CompletedNot Applicable

microRNA Expression in Renal Cell Carcinoma

Sun Yat-sen University1 site in 1 country50 target enrollmentStarted: July 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50
Locations
1

Study Overview

Brief Summary

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Detailed Description

Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients.

MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis.

In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with primary renal cell carcinoma.
  • Subjects who agree to participate in the study and sign the informed consent.

Exclusion Criteria

  • Patients with secondary renal cell carcinoma.
  • Subjects who refuse to participate in the study and sign the informed consent.

Investigators

Sponsor
Sun Yat-sen University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xue Qing Yu

Professor

Sun Yat-sen University

Study Sites (1)

Loading locations...

Similar Trials

microRNA Expression in Renal Cell Carcinoma | Clinical Trial